News & Events

ta-Scan SCOPE Europe 2018 Barcelona

SCOPE Europe 2018: Join us at the First European Edition

Join us in October at the inaugural edition of SCOPE Europe in Barcelona, Spain. Visit the ta-Scan team at booth #6 or make an appointment with our attendees:

Chairperson’s Remarks

David Cocker, CSO, ta-Scan Business Intelligence Systems, MDCPartners

DAY 1, Tuesday 16 October, 13:55h
David Cocker, Chief Scientific Officer, ta-Scan Business Intelligence Systems, MDCPartners / Anju Software
Track 1: Analytics-Driven Feasibility, Site Selection and Study Activation

 

 

About SCOPE Europe

Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical operations executives, functional heads, category managers and those responsible for the planning and management of clinical trials in Europe and the rest of the world. The event will feature opening and closing plenary keynote sessions, three conference tracks, interactive breakout discussion groups and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials. Topics to be discussed include protocol development, global site selection, feasibility, site management, patient engagement, enrollment planning, patient recruitment, patient retention, improving site-study activation and performance, functional/full-service outsourcing and partnerships, new regulations and guideline, Risk-Based Monitoring (RBM), and improving overall quality and speed of clinical trials.

Register to join us

Have a look at the agenda: http://www.scopesummiteurope.com/2018-brochure-download-form

Register here to join us in Barcelona: https://chidb.com/reg/scoe/reg.asp

We hope to see you there!

Share on:
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin

Anju Software Continues to Build the Next Generation Life Science Software and Data Platform Through Acquisition of MDCPartners

NEW YORK–Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired Antwerp-based MDCPartners, a company that specializes in business intelligence data solutions for clinical trial optimization, medical expert identification and competitive intelligence.

“MDCPartners will enable Anju to provide additional value added solutions to pharmaceutical, biotech and medical device companies. This acquisition strengthens Anju’s current product portfolio and can now provide up-to-date comprehensive data for Medical Expert Engagement and Clinical Trial Optimization. MDC, which is based in Belgium, also provides us with operations in Europe to better service our global customers,” said Mr. Kurien Jacob, CEO of Anju Software.

“Anju’s approach and philosophy provides us with financial strength and scale as well as additional resources to support our growth strategy and guide our clients over the long-term,” added Mireille De Cré, co-founder and CEO of MDCPartners.

“With the acquisition of MDCPartners, Anju continues its accelerated growth within the Medical Affairs and clinical trial sectors. Anju is now recognized as an emerging leader in the life science software industry, providing end-to-end software solutions that help customers manage mission critical pharma processes and turn data into actionable insights. We continue to be impressed with what the Anju management team, led by CEO Kurien Jacob, has been able to achieve in a short period of time,” said Gopi Vaddi, Managing Director of Providence Strategic Growth.

Snell and Wilmer acted as legal counsel to Anju and Madison Park Group acted as financial advisors to Anju on the transaction.

About Anju Software

Anju Software is a leading provider of comprehensive software solutions to the life sciences industry. The Company provides an integrated platform spanning clinical, medical affairs and after-market functions for pharmaceutical, biotech and medical device companies and clinical research organizations. Anju was founded by a group of operating professionals with deep software domain expertise and intent on building the next generation platform for the life sciences sector. Over the past two years, Anju has acquired five companies:

  • Online Business Applications – Market leader in medical information solutions and pharmacovigilance
  • OpenQ – Solutions for key opinion leader (KOL) engagement and management
  • ClinPlus – Provider of comprehensive electronic data capture (EDC), clinical trials management software (CTMS), electronic trial master file (eTMF) solutions
  • Sylogent – Clinical data capture and publishing planning solutions
  • MDCPartners – Business intelligence solutions

Anju Software is a portfolio company of Providence Strategic Growth, the growth equity affiliate of Providence Equity Partners, a global private equity firm with over $57 billion in capital under management.

About MDCPartners

MDCPartners provides business intelligence solutions for clinical trial optimization, medical expert identification and competitive intelligence. With deep expertise in the fields of data mining, semantic processing and engineering, MDC provides its clients with event-based tools to monitor and analyze an ever-expanding world of public and private data. With their proprietary data solutions, users can transform millions of scattered data points into a robust snapshot of a therapeutic area. MDC combines its expertise in drug development processes with its unique IT architecture to provide cost effective information solutions to the pharmaceutical and biotech industry. MDCPartners offers a product suite that includes: ta-Scan, a web-based data platform that helps users monitor, aggregate, and analyze regulatory data, trial data and expert profiles; normScan: web-based standards tracking tool tailored to clients’ product range; and Real World Solutions; a tool allowing the depiction of external client data merged with information from a public data cloud.

About Providence Equity

Providence is a premier global private equity firm with more than $57 billion in capital under management. Providence pioneered a sector-focused approach to private equity investing with the vision that a dedicated team of industry experts could build exceptional companies of enduring value. Since the firm’s inception in 1989, Providence has invested in more than 160 companies and is a leading equity investment firm focused on the media, communications, education and information industries. Providence is headquartered in Providence, RI, and also has offices in New York and London. For more information, please visit www.provequity.com.

Contacts

Anju Software
Kurien Jacob, +1 480-326-2358
kurien@anjusoftware.com

MDCPartners
Mireille De Cré
mireille.decre@mdcpartners.be

Providence Equity 
Sard Verbinnen & Co
Andrew Cole / Kelsey Markovich
Prov-SVC@SARDVERB.COM
+1 212-687-8080

View Business Wire press release: https://www.businesswire.com/news/home/20180621005656/en/Anju-Software-Continues-Build-Generation-Life-Science

Share on:
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
DIA Europe 2018 ta-Scan David Cocker

Celebrate the 30th DIA Europe with us in Basel!

The second meeting the ta-Scan team has in store for April is nothing less than the 30th edition of the DIA Europe 2018 meeting. That deserves a celebration!

Join us in Basel

If you want to get a demo of our clinical business intelligence solution ta-Scan and our newest developments, or learn more about our other (custom) software solutions, visit us at DIA Europe 2018 at booth #100 or make an appointment with the ta-Scan team:

You can register here.

DIA Europe 2018

2018 marks the 30th anniversary of the DIA EuroMeeting. To support this anniversary, and to align this European flagship meeting with all the DIA regional flagship meetings occurring across the globe, we are renaming the gathering, DIA Europe 2018. This new name reflects not only regional alignment but also a change in approach to more directly and proactively focus on the expressed needs and interests of our constituents. DIA Europe 2018 is more than just a traditional meeting. It’s a chance to learn, engage, and grow as a professional in health care.

We convene these platforms around the globe, from the DIA Global Annual Meeting in the United States, to regional meetings in China, Europe, India and Japan, to provide you with a neutral forum to discuss current issues, with the goal of uncovering new ways of working and new solutions for patients. We welcome participants from across the entire drug development industry. By incorporating representatives from the full life sciences landscape we facilitate open collaboration. We ensure that industry, payors, patients and regulators, all have an equal voice.

We look forward to welcoming everyone to DIA Europe’s home in Basel, Switzerland. Download the meeting programme here.

Share on:
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
eyeforpharma Medical Affairs USA 2018 ta-Scan Podium

Try out ta-Scan Podium at eyeforpharma Medical Affairs USA 2018

After what has been a very busy and successful SCOPE Summit in Orlando, the ta-Scan team is preparing for the next event: eyeforpharma Medical Affairs USA, hosted in Philadelphia, April 10-11. You can register now with code MDC200 for a $200 discount if you want to join us.

Identify Medical Experts easily with ta-Scan Podium

Next to a completely updated and optimized user interface, ta-Scan also has a new tool in store. Our mobile application ta-Scan Podium helps Medical Affairs teams and Medical Science Liaisons to identify the right Medical Experts. Have a look at how Podium works.

ta-Scan Podium Mobile Semantic Search tablet

Meet us in Philadelphia

If you want to get a demo of ta-Scan Podium and learn more about our other (custom) software solutions, visit us at eyeforpharma Medical Affairs USA 2018 at booth #12 or make an appointment with the ta-Scan team:

Register now with code MDC200 for a $200 discount.

eyeforpharma Medical Affairs USA

Medical Affairs as the change agent: bring data, authenticity and patient insight to the forefront of every decision your company makes. Eyeforpharma Medical Affairs USA 2018 (April 10-11) will bring together medical leaders and other key stakeholders from across the industry, to aid the evolution of medical in becoming the ‘home’ of value within the organisation.

Catalysts create change. The reason why the medical department is the fastest-growing department in nearly every company is because change in every other team is essential. The need for more open, science-based dialog with HCPs has never been greater; patient voices are necessarily louder and more impactful than ever; and payers require far more real world, value-based evidence. View the meeting agenda here.

Share on:
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
SCOPE 2018 ta-Scan

MDCPartners announces 2018 innovation strategy this week at SCOPE Summit in Orlando (FL)

At the 9th annual SCOPE Summit, taking place in Orlando (Florida) this week, MDCPartners will present their two latest innovative designs to the public: ta-Scan Podium and InterSect. ta-Scan Podium is an online tablet application for Clinical Ops, Medical Affairs teams, and Medical Science Liaisons that enables users to find full profiles of all relevant Key Opinion Leaders and Key External Experts. InterSect is a desktop application that interfaces with the entire ta-Scan database on a semantic level. This unique query tool allows users to overlap internal data with the ta-Scan database and match and correlate the data in the system.

Both new innovative technologies are based on the organization’s well-known clinical business intelligence solution ta-Scan and its Semantic Search System. The patented Trial Cloud® and web mining software of ta-Scan, which is the largest semantically linked clinical database available on the web, combined with its powerful search capabilities, allow users to quickly find and analyze clinical data from multiple global public sources. The effortless delivery of in-depth and clear insights into any data point in the database is what classifies these tools as digital innovations.

This year’s SCOPE summit will focus on stimulating innovation, change, and personalized solutions to improve the clinical trial process. With hot topics such as clinical technology and innovation and artificial intelligence in clinical research, it’s important for exhibitors to stay on top of these latest developments. Where MDCPartners’ focus in the previous years was more on the introduction of new features and developments, this year it has shifted to more personalized solutions, with new modules being completely customizable to integrate private data.

“As a company which provides clinical intelligence, we believe it is crucial to gain greater insights into therapeutic area landscapes by using innovative and personalized solutions. That’s why we collaborate with our clients to answer the business questions they need. The goal of creating these new modules is not only to increase work efficiency, but also to make decision making more transparent and interoperable,” says CEO Mireille De Cré. MDCPartners will introduce the full product portfolio at the SCOPE summit and provide top pharma executives with private sessions to test and use the products live.

View GlobeNewswire press release: http://inpublic.globenewswire.com/releaseDetails.faces?rId=2168008

Share on:
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
ta-Scan SCOPE 2018

Catch up with ta-Scan during SCOPE 2018 at booth 300

On February 12-15, the ta-Scan team has its annual appointment with SCOPE 2018. Meet us in the Hyatt Regency in Orlando, Florida at booth 300 to discover what we have been working on the last year.

Identify Medical Experts easily with ta-Scan Podium

Next to a completely updated and optimized user interface, ta-Scan also has a new tool in store. Our mobile application ta-Scan Podium helps Clinical Ops, Medical Affairs teams, and Medical Science Liaisons to identify the right Medical Experts. Have a look at how Podium works.

ta-Scan Podium Mobile Semantic Search Expert Profiling

Meeting up

If you want to get an exclusive preview of Podium and learn more about our other (custom) software solutions, visit us on SCOPE 2018 at booth #300 or make an appointment with the ta-Scan team:

Summit for Clinical Operations Executives

The 9th Annual SCOPE Summit, taking place February 12-15, 2018 in Orlando, FL, will offer four stimulating days of in-depth discussions in 18 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions focused on advances and innovative solutions in all aspects of clinical trial planning, management and operations: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy & Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Resource Management and Capacity Planning, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence (AI), Post-Marketing Studies, Observational Research, Clinical Supply Chain, and Precision Medicine. View SCOPE’s programs here.

Share on:
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
ta-Scan Podium Mobile Semantic Search tablet

MDCPartners Introduces Medical Expert Search Tool for Biopharma with New “ta-Scan Podium” App

MDCPartners introduces ta-Scan Podium, an online application for Clinical Ops, Medical Affairs teams and Medical Science Liaisons. The technology is based on the organization’s well-known clinical business intelligence solution ta-Scan, which effortlessly delivers in-depth and clear profiles of all relevant Key Opinion Leaders and Key External Experts. The application also categorizes these expert profiles by their medical relevance and professional credentials. The ranking is based on the experts’ past and current clinical research activity and their experience levels within various disease areas.

The growing need for a user-friendly and up-to-date database of expert profiles led to the development of ta-Scan Podium. This mobile enterprise tool compresses hours of internet searching to a few clicks.

“Increasing scrutiny how pharma engages with therapeutic leaders has created a new demand in selection and evidence-based approaches to rank KOLs by fair market value,” commented David Cocker, Chief Scientific Officer at MDCPartners. ta-Scan Podium is powered by ta-Scan’s semantic search system: a user types in some medical filters, and ta-Scan Podium returns a list of potential KOL names, their rank, and therapeutic relevance. Tapping the résumé icon reveals a full profile. The patented Trial Cloud® and web mining software of ta-Scan, which is the largest semantically linked clinical database available on the web, combined with its powerful search capabilities, allows users to quickly find and analyze clinical expert data from multiple global public sources.

This new mobile application is a milestone in the product portfolio of MDCPartners. As a company which provides clinical intelligence and consultancy, MDCPartners believes it is crucial to gain greater insights into the therapeutic area expert landscape.

ta-Scan Podium Mobile Semantic Search tablet

View GlobeNewswire press release: http://inpublic.globenewswire.com/releaseDetails.faces?rId=2157986

Share on:
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin

Find medical experts on the go with ta-Scan Podium

With ta-Scan Podium, our new semantic search application, MDCPartners is going mobile. ta-Scan Podium allows you to leverage the powerful search capabilities of ta-Scan’s clinical intelligence database to find Key External Experts on the go, using any tablet device.

If you are moving into a new disease area or if you are trying to identify new therapeutic experts in an existing indication, why remain limited to the endless number of databases, only available on your desktop? Whether you’re at your desk, at a meeting or a conference, you can now search, refine, save, and share any expert profile with a few simple clicks on your tablet.

Learn more about Podium in the video below and see how it can improve your work effectiveness.
Book your free demo using the following link → https://www.ta-scan.com/podiumdemo

Share on:
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
Immuno-Oncology Summit 2017 ta-Scan analysis

Get your FREE Immuno-Oncology Therapy Analysis by ta-Scan

Today brings the start of the Immuno-Oncology Summit 2017 in Boston, supporting researchers in developing the next generation of immunotherapies. Immuno-oncology researchers are changing the way we treat cancer by unleashing the immune system and achieving functional cures in some cancers.

MDCPartners and its ta-Scan team contribute to this purpose by teaching how clinical planners can leverage our clinical businesses intelligence software and our data merging services to get to their answers faster. The ta-Scan team created a useful analysis on oncolytic virus therapies in clinical trials. We thought today would be a good occasion to share this report with you.

>>> Click here to download the analysis <<<

Share on:
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
ta-Scan and MDCPartners at Immuno-Oncology Summit 2017 Boston

Connect with MDCPartners at the Immuno-Oncology Summit 2017

Connect with MDCPartners at Immuno-Oncology Summit 2017 from August 28 to September 1, 2017 in Boston, MA. Visit MDCPartners at booth #32 to discover next generation targeted immunotherapies and find new ways to navigate clinical data and overlap internal data with MDCPartners’ public data cloud.

Join us in Boston

Would you like to know how our clinical business intelligence software ta-Scan or our other data solutions can help with your company’s data challenges? Then feel free to pop by booth #32 or make an appointment with MDCPartners’ Director of Business Development, North America Matt Tumasz and/or Strategic Analyst, Oncology, Dr. Jonathan Crowther. They will gladly show you our state of the art tools.

Register Today

Secure your place now if you want to connect with the ta-Scan team in Boston. MDCPartners has arranged for an exclusive discount on CHI’s Immuno-Oncology Summit. Use promo code MDC when registering to receive your $200 registration discount. This discount applies to conference programs only and cannot be used on short courses, combined with other offers, or transferred.

How to register:
Online: https://chidb.com/reg/imx/reg.asp
By Phone: +1 781-972-5472

Immuno-Oncology Summit 2017 Program

Now in its fifth year, the Immuno-Oncology Summit will return to Boston again this August 28-September 1 with the goal of supporting researchers in developing the next generation of immunotherapies. Immuno-oncology researchers are changing the way we treat cancer by unleashing the immune system and achieving functional cures in some cancers.

This year’s IO Summit has been designed to give attendees a complete picture of the field and its advances with 12 conference tracks, 1 in-depth training seminar, and 4 instructional short courses. Topics include immunotherapy discovery, development, biomarkers, and translational oncology as well as emerging topic areas such as cancer vaccines, oncolytic viruses, and advances in synthetic biology techniques. Overall, this event provides a focused look at how researchers are applying new science and technology in the development of effective and safe immunotherapies.

Download the digital brochure for full details.

We look forward to seeing you in Boston!

Share on:
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin

Categories

 

Tags

 

Connect with MDCPartners

Follow us on LinkedIn

Follow us on Twitter

Top of Page